BackAxsome Therapeutics Overview

Axsome Therapeutics Operating Income

Operating Income for AXSM.

Quarterly Operating Income

$-63357000.00
11.19% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-175610000.00
34.5% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)